Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("KOLLER, William C")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 75

  • Page / 3
Export

Selection :

  • and

Treatment of early Parkinson's diseaseKOLLER, William C.Neurology. 2002, Vol 58, Num 4, pp S79-S86, issn 0028-3878, SUP1Article

The evolving role of monoamine oxidase inhibitors in the treatment of Parkinson's diseaseKOLLER, William C.Neurology. 2004, Vol 63, Num 7, issn 0028-3878, 37 p., SUP2Serial Issue

Role of the controlled-release formulation of carbidopa-levodopa in the treatment of Parkinson's disease, Keystone, CO, March 7-10, 1991KOLLER, William C.Neurology. 1992, Vol 42, Num 1, issn 0028-3878, 56 p., SUP1Conference Proceedings

The new role of dopamine agonists in the management of Parkinson's disease and restless legs syndromeKOLLER, William C.Neurology. 2002, Vol 58, Num 4, issn 0028-3878, 94 p., SUP1Serial Issue

A novel formulation of selegiline for the treatment of Parkinson's diseaseTETRUD, James W; KOLLER, William C.Neurology. 2004, Vol 63, Num 7, pp S2-S6, issn 0028-3878, SUP2Article

Essential TremorKOLLER, William C; DEUSCHL, Günther.Neurology. 2000, Vol 54, Num 11, issn 0028-3878, 48 p., SUP4Serial Issue

Current and emerging drug therapies in the management of Parkinson's diseaseKOLLER, William C; TOLOSA, Eduardo.Neurology. 1998, Vol 50, Num 6, issn 0028-3878, 51 p., SUP6Conference Proceedings

Pharmacology of dopamine agonists in the treatment of Parkinson's diseaseJENNER, Peter.Neurology. 2002, Vol 58, Num 4, pp S1-S8, issn 0028-3878, SUP1Article

Optimization of levodopa therapyPFEIFFER, R.Neurology. 1992, Vol 42, Num 1, pp 39-43, issn 0028-3878, SUP1Conference Paper

Levodopa strengths and weaknessesJANKOVIC, Joseph.Neurology. 2002, Vol 58, Num 4, pp S19-S32, issn 0028-3878, SUP1Article

Preclinical evidence for neuroprotection with monoamine oxidase-B inhibitors in Parkinson's diseaseJENNER, Peter.Neurology. 2004, Vol 63, Num 7, pp S13-S22, issn 0028-3878, SUP2Article

Restless legs syndrome: Treatment with dopaminergic agentsCOMELLA, Cynthia L.Neurology. 2002, Vol 58, Num 4, pp S87-S92, issn 0028-3878, SUP1Article

An algorithm (decision tree) for the management of Parkinson's disease: treatment guidelinesOLANOW, C. Warren; KOLLER, William C.Neurology. 1998, Vol 50, Num 3, issn 0028-3878, 60 p., SUP3Serial Issue

Adjuncts to levodopa therapy : Dopamine agonistsPOEWE, W.Neurology. 1998, Vol 50, Num 6, pp S23-S26, issn 0028-3878, SUP6Conference Paper

The use of sinemet CR in the management of mild to moderate Parkinson's diseaseRODNITZKY, R. L.Neurology. 1992, Vol 42, Num 1, pp 44-50, issn 0028-3878, SUP1Conference Paper

Unmet medical needs in Parkinson's diseaseKOLLER, William C; TSE, Winona.Neurology. 2004, Vol 62, Num 1, pp S1-S8, issn 0028-3878, SUP1Article

The role of dopamine agonists in the treatment of early Parkinson's diseaseOLANOW, C. Warren.Neurology. 2002, Vol 58, Num 4, pp S33-S41, issn 0028-3878, SUP1Article

Long-term studies of dopamine agonistsHUBBLE, Jean P.Neurology. 2002, Vol 58, Num 4, pp S42-S50, issn 0028-3878, SUP1Article

Tremor and dopamine agonistsELBLE, Rodger J.Neurology. 2002, Vol 58, Num 4, pp S57-S62, issn 0028-3878, SUP1Article

Tremor assessment and quality of life measurementsBAIN, P. G.Neurology. 2000, Vol 54, Num 11, pp S26-S29, issn 0028-3878, SUP4Article

Clinical trials of neuroprotection for Parkinson's diseaseLEWITT, Peter A.Neurology. 2004, Vol 63, Num 7, pp S23-S31, issn 0028-3878, SUP2Article

Implications of the 5-year CR FIRST trialCAPILDEO, R.Neurology. 1998, Vol 50, Num 6, pp S15-S17, issn 0028-3878, SUP6Conference Paper

Managing the neuropsychiatric symptoms of Parkinson's diseaseLIEBERMAN, A.Neurology. 1998, Vol 50, Num 6, pp S33-S38, issn 0028-3878, SUP6Conference Paper

Effect of levodopa treatment for parkinsonism in welders: A double-blind studyKOLLER, William C; LYONS, Kelly E; TRULY, William et al.Neurology. 2004, Vol 62, Num 5, pp 730-733, issn 0028-3878, 4 p.Article

The comparative effects of medical therapies for Parkinson's diseaseHORN, Stacy; STERN, Matthew B.Neurology. 2004, Vol 63, Num 7, pp S7-S12, issn 0028-3878, SUP2Article

  • Page / 3